{"title":"FGL-1 Modulates Inter-Organ Communication by Controlling T Cell Homeostasis during the Onset of Sjögren's Disease.","authors":"Kunihiro Otsuka,Aya Ushio,Ruka Nagao,Shigefumi Matsuzawa,Rieko Arakaki,Kazuki Fukuta,Yasuhiro Mouri,Takaaki Tsunematsu,Naozumi Ishimaru","doi":"10.1002/art.43236","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nAutoimmunity occurs due to the tactics between pathogenic and regulatory factors in systemic organs. Although inter-organ communication has been demonstrated in various diseases, the effects of the crosstalk between the immune system and other organs on autoimmune disease is unknown.\r\n\r\nMETHODS\r\nWe analyzed the influence of inter-organ communication on the cellular or molecular mechanism of autoimmunity using a mouse model of primary Sjögren's disease (pSjD) and patients with pSjD by integrative genomic, bioinformatics, pathological, and immunological analyses.\r\n\r\nRESULTS\r\nFibrinogen-like protein-1 (FGL-1) was identified as a potent factor for inter-organ communication between the liver and immune system in pSjD model mice. The production of FGL-1 of the liver is induced by IL-6 from CD4+ T cells in these mice. The onset of autoimmune lesions in Fgl1-deficient pSjD model mice was earlier than that in the WT-pSjD model mice. FGL-1 produced in the liver regulates naïve/memory T cell homeostasis. Further, FGL-1 was significantly upregulated in patients with pSjD compared to the controls. Moreover, its concentration was closely related to the serum IL-6 levels in patients with pSjD.\r\n\r\nCONCLUSION\r\nFGL-1 plays a key role in the onset of autoimmunity by suppressing T cell activation in pSjD. Our results will facilitate the development of novel diagnostic or therapeutic strategies targeting the inter-organ communication for autoimmune diseases.","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"55 1","pages":""},"PeriodicalIF":10.9000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthritis & Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/art.43236","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE
Autoimmunity occurs due to the tactics between pathogenic and regulatory factors in systemic organs. Although inter-organ communication has been demonstrated in various diseases, the effects of the crosstalk between the immune system and other organs on autoimmune disease is unknown.
METHODS
We analyzed the influence of inter-organ communication on the cellular or molecular mechanism of autoimmunity using a mouse model of primary Sjögren's disease (pSjD) and patients with pSjD by integrative genomic, bioinformatics, pathological, and immunological analyses.
RESULTS
Fibrinogen-like protein-1 (FGL-1) was identified as a potent factor for inter-organ communication between the liver and immune system in pSjD model mice. The production of FGL-1 of the liver is induced by IL-6 from CD4+ T cells in these mice. The onset of autoimmune lesions in Fgl1-deficient pSjD model mice was earlier than that in the WT-pSjD model mice. FGL-1 produced in the liver regulates naïve/memory T cell homeostasis. Further, FGL-1 was significantly upregulated in patients with pSjD compared to the controls. Moreover, its concentration was closely related to the serum IL-6 levels in patients with pSjD.
CONCLUSION
FGL-1 plays a key role in the onset of autoimmunity by suppressing T cell activation in pSjD. Our results will facilitate the development of novel diagnostic or therapeutic strategies targeting the inter-organ communication for autoimmune diseases.
期刊介绍:
Arthritis & Rheumatology is the official journal of the American College of Rheumatology and focuses on the natural history, pathophysiology, treatment, and outcome of rheumatic diseases. It is a peer-reviewed publication that aims to provide the highest quality basic and clinical research in this field. The journal covers a wide range of investigative areas and also includes review articles, editorials, and educational material for researchers and clinicians. Being recognized as a leading research journal in rheumatology, Arthritis & Rheumatology serves the global community of rheumatology investigators and clinicians.